MAPT and Alzheimer disease: Together, our findings confirmed neuronal loss and abnormal elevation of Aβ and Tau in the hippocampus and cortex of hyperglycemic 3 × Tg‐AD mice and LM‐031 treatment could rescue these pathologic changes.